Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ?
Author:
Affiliation:
1. Division of Nephrology; Hennepin Healthcare Systems; Minneapolis MN USA
2. Chronic Disease Research Group; Minneapolis Medical Research Foundation; Minneapolis MN USA
Publisher
Wiley
Subject
Nephrology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/sdi.12734/fullpdf
Reference31 articles.
1. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease;Levin;Kidney Int,2007
2. Pathogenesis of secondary hyperparathyroidism;Slatopolsky;Kidney Int Suppl,1999
3. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options;Cunningham;Clin J Am Soc Nephrol,2011
4. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study;Block;Am J Kidney Dis,1998
5. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis;Block;J Am Soc Nephrol,2004
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Etelcalcetide use During Maintenance Hemodialysis and Incidence of Parathyroidectomy After Kidney Transplantation;Kidney International Reports;2024-07
2. Pharmaceutical Management of Secondary Hyperparathyroidism and the Role of Surgery: A 5-Year Retrospective Study;Medicina;2024-05-15
3. Pathophysiology and Clinical Impacts of Chronic Kidney Disease on Coronary Artery Calcification;Journal of Cardiovascular Development and Disease;2023-05-10
4. Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model;Bone;2023-02
5. Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation;Healthcare;2022-12-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3